List I (Complex) | List II (Type of isomerism) |
A. \(\left[\mathrm{Co}\left(\mathrm{NH}_3\right)_5\left(\mathrm{NO}_2\right)\right] \mathrm{Cl}_2\) | I. Solvate isomerism |
B. \(\left[\mathrm{Co}\left(\mathrm{NH}_3\right)_5\left(\mathrm{SO}_4\right)\right] \mathrm{Br}\) | II. Linkage isomerism |
C. \(\left[\mathrm{Co}\left(\mathrm{NH}_3\right)_6\right]\left[\mathrm{Cr}(\mathrm{CN})_6\right]\) | III. Ionization isomerism |
D. \(\left[\mathrm{Co}\left(\mathrm{H}_2 \mathrm{O}\right)_6\right] \mathrm{Cl}_3\) | IV. Coordination |
List-I (Complexes) | List-II (Type of isomer) | ||
A. | [Co(NH3)5NO2]Cl2 and [Co(NH3)5ONO]Cl2 | I. | Ionisation isomerism |
B. | [Cr(NH3)6] [Co(CN)6] and [Cr(CN)6][Co(NH3)6] | II. | Coordination isomerism |
C. | [Co(NH3)5(SO4)]Br and [Co(NH3)5Br]SO4 | III. | Linkage isomerism |
D. | [Cr(H2O)6]Cl3 and [Cr(H2O)5Cl]Cl2.H2O | IV. | Solvate isomerism |
(A) | (B) | (C) | (D) | |
1. | (III) | (I) | (II) | (IV) |
2. | (II) | (III) | (IV) | (I) |
3. | (III) | (II) | (I) | (IV) |
4. | (IV) | (III) | (II) | (I) |
1. | Geometrical isomerism | 2. | Coordination isomerism |
3. | Ionization isomerism | 4. | Linkage isomerism |
The number of possible isomers for the complex will be (en=ethylenediamine):
1. 2
2. 1
3. 3
4. 4
An anticancer agent among the following is:
1.
2. c
3. c
4.
The complexes [Co(NH3)6][Cr(CN)6] and [Cr(NH3)6][Co(CN)6] show:
1. Ionisation isomerism
2. Co-ordination isomerism
3. Geometrical isomerism
4. Linkage isomerism
The number of geometrical isomers shown by are:
1. | 4 | 2. | 0 |
3. | 2 | 4. | 3 |
The existence of two different coloured complexes with the composition of [Co(NH3)4Cl2]+is due to:
1. Linkage isomerism
2. Geometrical isomerism
3. Coordination isomerism
4. Ionisation isomerism
Identify the complex among the following that is not expected to exhibit isomerism:
1. [Pt(NH3)2Cl2]
2. [Ni(NH3)2Cl2]
3. [Ni(en)3]2+
4. [Ni(NH3)4(H2O)2]2+